Xtant Medical gained FDA 510(k) clearance for its InTice™-C Porous Titanium Cervical Interbody System. InTice-C uses OsteoSync Ti, a highly porous titanium scaffold material that more closely resembles the bioscaffold of cancellous bone.
InTice-C is also cleared for use with Xtant’s proprietary allograft lines, including OsteoSponge®, 3Demin® Cortical Fibers, and OsteoVive™ viable cell allograft.
This is Xtant’s first spinal implant to use porous titanium.
Source: Xtant Medical Holdings, Inc.
Xtant Medical gained FDA 510(k) clearance for its InTice™-C Porous Titanium Cervical Interbody System. InTice-C uses OsteoSync Ti, a highly porous titanium scaffold material that more closely resembles the bioscaffold of cancellous bone.
InTice-C is also cleared for use with Xtant's proprietary allograft lines, including OsteoSponge®, 3Demin®...
Xtant Medical gained FDA 510(k) clearance for its InTice™-C Porous Titanium Cervical Interbody System. InTice-C uses OsteoSync Ti, a highly porous titanium scaffold material that more closely resembles the bioscaffold of cancellous bone.
InTice-C is also cleared for use with Xtant’s proprietary allograft lines, including OsteoSponge®, 3Demin® Cortical Fibers, and OsteoVive™ viable cell allograft.
This is Xtant’s first spinal implant to use porous titanium.
Source: Xtant Medical Holdings, Inc.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.